«SCORE-CoV-2» and its relation to GDP performance
Main Article Content
Abstract
In the global context, which has been affected by the virus SARS-CoV-2, each country had a specific way of managing its population, so an evaluation system is proposed (named «SCORE-CoV-2»), which aims to synthesize the actions and results of the countries to face the pandemic, taking into account eight variables. The COVID-19 pandemic has dealt a blow to the world economy; World Bank figures expect a global contraction of 5.2 % of gross domestic product (GDP) in 2020, pushing millions into extreme poverty. The hypothesis proposes that the SCORE-CoV-2 value will have a significant relationship with the behavior of the countries’ GDP, being a predictor of certainty about the evolution of the countries’ economies. After performing the respective statistical analysis, the Pearson correlation (R2 <0.001) showed a lack of relationship between the scoring system and the GDP value per country, but it was possible to analyze the points in which each country has a low score, and thus propose new specific management of each nation’s deficit in COVID-19 issues.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional.
References
global and Turkish economy». Turkish Journal of Medical Sciences, 50 (SI-1), 520-526.
Andrus, J., Evans, T., Santos, J., Guzman, M., Rosenthal, P., Toscano, C., Valenzuela, M.
T., Siqueira, M., Etienne, C. y Breman, J. (2020). «Perspectives on Battling COVID-19
in Countries of Latin America and the Caribbean». The American Journal of Tropical
Medicine and Hygiene, 103 (2), 593-596. https://doi.org/10.4269/ajtmh.20-0571
Aziz, N., Othman, J., Lugova, H. y Suleiman, A. (2020). «Malaysia’s approach in
handling COVID-19 onslaught: Report on the Movement Control Order (MCO)
and targeted screening to reduce community infection rate and impact on public
health and economy». Journal of Infection and Public Health, 13 (12), 1823-1829.
Banco Mundial. (8 de junio de 2020). «La COVID-19 (coronavirus) hunde a la economía
mundial en la peor recesión desde la Segunda Guerra Mundial» (comunicado
de prensa). https://www.bancomundial.org/es/news/press-release/2020/06/08/
covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii
Caicedo, Y., Rebellón, D., Peñaloza, M., Cortés, H. y Méndez, Y. (2020). «Effective
Reproductive Number estimation for initial stage of COVID-19 pandemic in Latin
American Countries». International Journal of Infectious Diseases, 95, 316-318.
Cavallo, J. y Forman, H. (2020). «The Economic Impact of the COVID-19 Pandemic on
Radiology Practices». Radiology, 296 (3), E141-E144.
Centers for Disease Control and Prevention. (2021). «Masks. Guidance for Unvaccinated
People». CDC. Recuperado el 14 de marzo de 2021 de: https://www.cdc.
gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html
Cepal-OPS. (2020). Salud y economía: una convergencia necesaria para enfrentar el
COVID-19 y retomar la senda hacia el desarrollo sostenible en América Latina y
el Caribe (pp. 1-27). OPS-Naciones Unidas.
«Coronavirus en Rusia hoy 4 septiembre: 1.015.110 casos de Covid-19 en el país
ruso». (4 de agosto de 2020). El Plural. Recuperado el 15 de marzo de 2021 de:
https://www.elplural.com/sociedad/rusia-manda-80-repatriados-rusos-wuhansiberia_
232654102
Delgado, D., Wyss, F., Perez, G., Sosa, A., Ponte, C., Mendoza, I. y Baranchuk, A. (2020).
«Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of
Healthcare Workers in Latin America». International Journal of Environmental
Research and Public Health, 17 (8). https://doi.org/10.3390/ijerph17082798
«Desarrolla Rusia tres fármacos contra la pandemia». (31 de marzo de 2020). La
Jornada. Recuperado el 14 de marzo de 2021 de: https://www.jornada.com.mx/
ultimas/ciencias/2020/03/31/desarrolla-rusia-tres-farmacos-contra-la-pandemia-
4368.html
Ferrer, R. (2020). «Pandemia por COVID-19: el mayor reto de la historia del intensivismo
». Medicina Intensiva, 44 (6), 323-324. Recuperado el 14 de marzo de 2021 de:
https://www.clinicalkey.es/#!/content/journal/1-s2.0-S2173572720301272
Ferreira, C., Bonvehi, P., Torre, J. de la, Sáenz, K. y Condino, A. (2021). «Algorithms for
testing COVID-19 focused on use of RT-PCR and high-affinity serological testing: A
consensus statement from a panel of Latin American experts». International Journal
of Infectious Diseases, 103, 260-267. https://doi.org/10.1016/j.ijid.2020.11.173
Fondo Monetario Internacional. (2021). World Economic Outlook Database (Base de
datos del panorama de la economía mundial). Recuperado el 4 de abril de 2021
de: https://www.imf.org/en/Publications/WEO/weo-database/2021/April
Gobierno de México. (2021). Capacitación. Recuperado el 15 de marzo de 2021 de:
https://coronavirus.gob.mx/capacitacion/
Gobierno de México, Secretaría de Salud. (2021). Versión estenográfica. Conferencia
de prensa. Informe diario sobre coronavirus COVID-19 en México. Recuperado
el 15 de marzo de 2021 de: https://www.gob.mx/salud/prensa/version-estenografica-
conferencia-de-prensa-informe-diario-sobre-coronavirus-covid-19-enmexico-
265289?idiom=es
Han, E., Tan, M., Turk, E., Sridhar, D., Leung, G. y Shibuya, K. et al. (2020). «Lessons
learnt from easing COVID-19 restrictions: an analysis of countries and regions
in Asia Pacific and Europe». The Lancet, 396 (10261), 1525-1534. https://doi.
org/10.1016/s0140-6736(20)32007-9
Ibarra, I., Cárdenas, J., Ruiz, R. y Salazar, R. (2020). «Mexico and the COVID-19
Response». Disaster Medicine and Public Health Preparedness, 14(4), e17–e18.
Islam, K. e Iqbal, J. (2020). «An Update on Molecular Diagnostics for COVID-19». Frontiers in
Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.560616
Khan, M., Adil, S., Adil, S., Alkhathlan, H., Tahir, M., Saif, S. y Khan, M. (2020). «COVID-19:
A Global Challenge with Old History, Epidemiology and Progress So Far». Molecules,
26 (1), 39.
Li, Y., Chi, W., Su, J., Ferrall, L., Hung, C. y Wu, T. (2020). «Coronavirus vaccine development:
from SARS and MERS to COVID-19». Journal of Biomedical Science, 27 (1), 104.
Logunov, D., Dolzhikova, I., Zubkova, O., Tukhvatulin, A., Shcheblyakov, D., Dzharullaeva,
A. et al. (2020). «Safety and immunogenicity of an rAd26 and rAd5 vector-
based heterologous prime-boost COVID-19 vaccine in two formulations: two
open, non-randomised phase 1/2 studies from Russia». The Lancet, 396 (10255),
887–897. https://doi.org/10.1016/S0140-6736(20)31866-3
Medeiros de Figueiredo, A., Daponte, A., Moreira Marculino de Figueiredo, D., Gil-García,
E. y Kalache, A. (2020). «Letalidad del COVID-19: ausencia de patrón epidemiológico
». Gaceta Sanitaria, 1855, 3. https://doi.org/10.1016/j.gaceta.2020.04.001
Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A., Iosifidis, C., Agha, M., Agha,
R. (2020). «The socio-economic implications of the coronavirus pandemic
(COVID-19): A review». International Journal of Surgery, 78, 185-193. https://10.
1016/j.ijsu.2020.04.018
Organización Mundial de la Salud, OMS. (2020). «Consejos para la población sobre el
nuevo coronavirus (2019-nCoV): cuándo y cómo usar mascarilla». OMS. Recuperado
el 14 de marzo de 2021 de: https://www.who.int/es/emergencies/diseases/
novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks
Our World in Data. (2021). Coronavirus (COVID-19) Cases - Statistics and Research
(base de datos). Recuperado el 15 de marzo de 2021 de: https://ourworldindata.
org/covid-cases?country=~OWID_WRL
Pardhan, S. y Drydakis, N. (2020). «Associating the Change in New COVID-19 Cases
to GDP per Capita in 38 European Countries in the First Wave of the Pandemic».
Front Public Health, 8 (1). https://dx.doi.org/10.3389%2Ffpubh.2020.582140
Ribeiro, V., Telles, J. y Tuon, F. (2020). «Arboviral diseases and COVID-19 in Brazil:
Concerns regarding climatic, sanitation, and endemic scenario». Journal of Medical
Virology, 92 (11), 2390-2391.
Rodriguez-Morales, A., Gallego, V., Escalera, J., Méndez, C., Zambrano, L., Franco , C.
et al. (2020). «COVID-19 in Latin America: The Implications of the First Confirmed
case in Brazil». Travel Medicine and Infectious Disease, 35. https://doi.org/10.1016/j.
tmaid.2020.101613
Rothan, H. y Byrareddy, S. (2020). «The epidemiology and pathogenesis of coronavirus
disease (COVID-19) outbreak». Journal of Autoimmunity, 109. https://doi.
org/10.1016/j.jaut.2020.102433
«Rusia superó los 4 millones de casos de coronavirus». (10 de febrero de 2021).
INFOBAE. Recuperado el 14 de marzo de 2021 de: https://www.infobae.com/america/
mundo/2021/02/10/rusia-supero-los-4-millones-de-casos-de-coronavirus/
Secretaría de Salud. Sistema de Información de la Red IRAG. (s/f). Ocupación de camas
en hospitalización general 2021-03-01. Recuperado el 15 de marzo de 2021
de: https://www.gits.igg.unam.mx/red-irag-dashboard/reviewHome
Setiati, S. y Azwar, M. (2020). «Dilemma of Prioritising Health and the Economy During
COVID-19 Pandemic in Indonesia». Acta Médica Indonesiana, 52 (3), 196-198.
Shrestha, N., Shad, M., Ulvi, O., Khan, M., Karamehic, A., Nguyen, U., et al. (2020). «The
impact of COVID-19 on globalization». One Health, 11. https://doi.org/10.1016/j.
onehlt.2020.100180
Universidad Nacional Autónoma de México, UNAM. (2020). Rusia y el Coronavirus.
Recuperado el 13 de marzo de 2021 de: https://unamglobal.unam.mx/rusia-y-elcoronavirus/
V’kovski, P., Kratzel, A., Steiner, S., Stalder, H., y Thiel, V. (2021). «Coronavirus biology
and replication: implications for SARS-CoV-2». Nature reviews. Microbiology, 19 (3),
155-170.
Wouters, O., Shadlen, K., Salcher-Konrad, M., Pollard, A., Larson, H., Teerawattananon,
Y. y Jit, M. (2021). «Challenges in ensuring global access to COVID-19
vaccines: production, affordability, allocation, and deployment». The Lancet, 397
(10278), 1023-1034. https://doi.org/10.1016/s0140-6736(21)00306-8
Zhao, J., Zhao, S., Ou, J., Zhang, J., Lan, W., Guan, W., Wu, X., Yan, Y., Zhao, W.,
Wu, J., Chodosh, J. y Zhang, Q. (2020). «COVID-19: Coronavirus Vaccine Development
Updates». Frontiers in Immunology, 11. https://doi.org/10.3389/
fimmu.2020.602256